4D Molecular Therapeutics (FDMT) Selling, General & Administrative (2020 - 2026)
4D Molecular Therapeutics (FDMT) reported Selling, General & Administrative of $12.52 million for Q2 2026, up 8.7% from $11.52 million a year earlier and up 7.2% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, 4D Molecular Therapeutics' Selling, General & Administrative came in at $48.82 million, down 2.6% year-over-year; for FY2025, it was $49.06 million, up 5.3% from FY2024.
- Selling, General & Administrative has increased for six consecutive years, with a five-year compound annual growth rate of 23.3% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $46.58 million in FY2024 (+27.6%), $36.49 million in FY2023 (+10.9%), $32.91 million in FY2022 (+17.5%) and $28.01 million in FY2021 (+62.5%).
- Five-year quarterly Selling, General & Administrative spans a low of $7.33 million in Q4 2021 and a high of $13.03 million in Q4 2024.
- Year over year, Selling, General & Administrative gained in five of the last eight quarters, with growth averaging 10.8%.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2021 (growth of 122.4%); the low point was Q1 2026 (a decline of 9.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.69 million (Q1 2026), $12.77 million (Q4 2025) and $11.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | 4D Molecular Therapeutics | 1.01 Bn | -454.35 Mn | - | 12.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Mn |
| Mar 31, 2026 | 11.69 Mn |
| Dec 31, 2025 | 12.77 Mn |
| Sep 30, 2025 | 11.84 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Mar 31, 2025 | 12.94 Mn |
| Dec 31, 2024 | 13.03 Mn |
| Sep 30, 2024 | 12.65 Mn |
| Jun 30, 2024 | 10.60 Mn |
| Mar 31, 2024 | 10.29 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Jun 30, 2023 | 8.79 Mn |
| Mar 31, 2023 | 7.99 Mn |
| Dec 31, 2022 | 8.47 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Mar 31, 2022 | 8.23 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 8.19 Mn |
API Access
4D Molecular Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();